We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BN:EURONEXT PARISDanone SA Analysis

Data as of 2026-03-10 - not real-time

$41.08

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Brookfield Corporation is trading close to a key support level with the Relative Strength Index signaling oversold conditions, while the MACD remains in a bearish configuration, indicating limited short‑term momentum. Volatility is elevated and the stock’s beta suggests it moves more aggressively than the broader market, amplifying price swings. The price‑to‑earnings multiple is markedly higher than the sector average, pointing to an overvalued valuation despite a modest revenue growth rate and solid gross margins. Dividend yield is low and the payout ratio, combined with zero reported operating cash flow, raises questions about the sustainability of the current dividend.
On the fundamentals side, the company carries a substantial debt load relative to equity, which, together with a low return on equity, underscores balance‑sheet pressure. However, analysts’ target prices imply a meaningful upside potential, and the diversified asset‑management platform offers long‑term exposure to real‑estate, infrastructure and renewable energy assets. The mix of high valuation, strong earnings potential and considerable risk factors suggests a cautious stance, with any upside hinging on a turnaround in cash generation and a moderation of leverage.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Oversold RSI suggests a potential bounce but limited momentum
  • Proximity to technical support level
  • High valuation relative to peers

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated debt-to-equity ratio
  • Questionable dividend sustainability
  • Neutral trend with bearish MACD

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Analyst target price indicating upside potential
  • Diversified asset base across real‑estate and renewable sectors
  • High volatility and beta increasing exposure to market swings

Key Metrics & Analysis

Financial Health

Revenue Growth3.50%
Profit Margin1.68%
P/E Ratio83.8
ROE1.95%
ROA2.55%
Debt/Equity158.50
P/B Ratio2.1
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI31.0
Support$39.63
Resistance$48.79
MA 20$45.14
MA 50$46.09
MA 200$44.42
MACDBearish
VolumeStable
Fear & Greed Index75.89

Valuation

Target Price$53.95
Upside/Downside31.33%
GradeOvervalued
TypeBlend
Dividend Yield0.68%

Risk Assessment

Beta1.44
Volatility34.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.